Editorial comment on: effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.
Gratzke
Christian
C
D000818:Animals; D001572:Benzofurans / Q000008:administration & dosage*; D005260:Female; D007275:Injections, Intravenous; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D010388:Pelvis / Q000294:innervation*; D011312:Pressure; D011759:Pyrrolidines / Q000008:administration & dosage*; D051381:Rats; D043587:Receptor, Muscarinic M3 / Q000037:antagonists & inhibitors*; D001743:Urinary Bladder / Q000294:innervation* / Q000502:physiology; D014563:Urodynamics / Q000187:drug effects / Q000502:physiology
D001572:Benzofurans; D018727:Muscarinic Antagonists; D011759:Pyrrolidines; D043587:Receptor, Muscarinic M3; C101207:darifenacin